ArticleScientific reports2025

Low levels of tumor suppressor miR-3619 in plasma contribute to malignant outcomes and a target for nucleic acid therapy in esophageal cancer.

Hiroshi Arakawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.